We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
3qfd
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:3qfd. | + | [[Image:3qfd.png|left|200px]] |
<!-- | <!-- | ||
| Line 11: | Line 11: | ||
===Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide=== | ===Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21937447}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21937447 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21937447}} | ||
==About this Structure== | ==About this Structure== | ||
[[3qfd]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3QFD OCA]. | [[3qfd]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3QFD OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:021937447</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Baker, B M.]] | [[Category: Baker, B M.]] | ||
Revision as of 05:44, 5 October 2011
Human Class I MHC HLA-A2 in complex with Mart-1(27-35) nonameric peptide
Template:ABSTRACT PUBMED 21937447
About this Structure
3qfd is a 6 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Insaidoo F, Borbulevych OY, Hossain M, Santhanagopolan SM, Baxter TK, Baker BM. Loss of T cell antigen recognition arising from changes in peptide and major histocompatibility complex protein flexibility: implications for vaccine design. J Biol Chem. 2011 Sep 21. PMID:21937447 doi:10.1074/jbc.M111.283564
